191 related articles for article (PubMed ID: 3744767)
1. Health technology assessment. The current political framework: the U.S. perspective.
Young FE
Isr J Med Sci; 1986; 22(3-4):173-8. PubMed ID: 3744767
[No Abstract] [Full Text] [Related]
2. Federal Policy toward health care technology: the case of the National Center.
Blumenthal D
Milbank Mem Fund Q Health Soc; 1983; 61(4):584-613. PubMed ID: 6557372
[No Abstract] [Full Text] [Related]
3. Medical technology: policies and problems.
Banta D; Behney CJ
Health Care Manage Rev; 1980; 5(4):45-52. PubMed ID: 7429818
[TBL] [Abstract][Full Text] [Related]
4. Review of medical technology policies shows need, opportunities for changes.
Banta D
Hospitals; 1982 Apr; 56(7):87-90. PubMed ID: 6800914
[No Abstract] [Full Text] [Related]
5. Clear-cut biotechnology regulations are a must.
Jefferson EG
Med Mark Media; 1985 Jul; 20(7):28-9, 32-3. PubMed ID: 10272849
[No Abstract] [Full Text] [Related]
6. Regulating biotechnology.
McGarity TO
Issues Sci Technol; 1985; 1(3):40-56. PubMed ID: 11649701
[No Abstract] [Full Text] [Related]
7. Who should be responsible?
Brown E
Physician Exec; 1996 Jun; 22(6):38-9. PubMed ID: 10158532
[No Abstract] [Full Text] [Related]
8. Role of the federal Government in health and medical affairs.
Lee PR
N Engl J Med; 1968 Nov; 279(21):1139-47. PubMed ID: 5686482
[No Abstract] [Full Text] [Related]
9. Assessment and approval of medical devices used in diagnostic imaging in the United States.
Johnson GC
Isr J Med Sci; 1986; 22(7-8):505-18. PubMed ID: 3536797
[TBL] [Abstract][Full Text] [Related]
10. Sounding board hard times for the national centers.
Bunker JP
N Engl J Med; 1980 Sep; 303(10):580-2. PubMed ID: 6772951
[No Abstract] [Full Text] [Related]
11. Technology transfer: U.S. scientists faulted on biotech consulting.
Kaiser J
Science; 2004 May; 304(5675):1222. PubMed ID: 15166331
[No Abstract] [Full Text] [Related]
12. Must an interest be a conflict?
Lyles A
Clin Ther; 2005 Mar; 27(3):344-5. PubMed ID: 15878388
[No Abstract] [Full Text] [Related]
13. Executive summary from the final reports of the National Committee to Review Current Procedures for Approval of New Drugs for Cancer and AIDS.
Oncology (Williston Park); 1991 Apr; 5(4):16, 18-9. PubMed ID: 1831034
[No Abstract] [Full Text] [Related]
14. Washington Report. Health-care technology: a small office vs. a big problem.
Greenberg DS
N Engl J Med; 1980 Jan; 302(4):243-4. PubMed ID: 7350476
[No Abstract] [Full Text] [Related]
15. View from the Nation's Capitol.
Freishtat HW
J Clin Psychopharmacol; 1982 Apr; 2(2):146-8. PubMed ID: 6926924
[No Abstract] [Full Text] [Related]
16. Organizational history of HSMHA.
Sims LB
Health Serv Rep; 1973 Feb; 88(2):117-23. PubMed ID: 4358689
[No Abstract] [Full Text] [Related]
17. Environmental health activities in the Public Health Service.
Lisella FS; Houk VN
J Environ Health; 1975; 37(6):571-3. PubMed ID: 10313851
[No Abstract] [Full Text] [Related]
18. Unified agenda of federal regulatory and deregulatory actions--HHS. Semiannual regulatory agenda.
Fed Regist; 1998 Nov; 63(216 Pt 2):61680-786. PubMed ID: 10187396
[TBL] [Abstract][Full Text] [Related]
19. National and international viral reagents programs.
Byrne RJ
Am J Vet Res; 1980 Mar; 41(3):408-9. PubMed ID: 6768333
[TBL] [Abstract][Full Text] [Related]
20. Whither the ELSI program?
Roberts L
Hastings Cent Rep; 1993; 23(6):5. PubMed ID: 8307748
[No Abstract] [Full Text] [Related]
[Next] [New Search]
